Companies Cryptocurrencies
OptiNose Inc
OptiNose Inc
Exchange: Nasdaq Global Select
IPO Date: 13/10/2017
CEO: Mr. Peter Miller
Drug Manufacturers General Specialty & Generic Healthcare đź”—
  • OPTN
  • 2.03
  • 167842432
    market cap
  • 0.17999995
If you bought

shares of OptiNose Inc (OPTN) on
You would have made
Old Price $12 Current Price $12

OptiNose, Inc. operates as a pharmaceutical company. The company is headquartered in Yardley, Pennsylvania and currently employs 99 full-time employees. The firm is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation.

Address: 1020 Stony Hill Rd Ste 300 Yardley PENNSYLVANIA 19067

Stay updated.